Utilizing cationic lipid-assisted poly(ethylene glycol)-block-poly(d,l-lactide) (PEG5K-PLA11K) nanoparticles for the delivery of CDK1-specific siRNA has shown potential in inhibiting tumor growth by effectively silencing CDK1 expression (Figure 7B) [188]. The gene discussed is CDK1; the disease is neoplasm.